1. Esiri MM, Kennedy PGE. Virus Disease.
Greenfields’s Neuropathology’de. Ed. Adams
JH, Duchen LW. Altıcı Baskı. Londra, Sidney,
Aucland,: Arnold 1997; Vol. II 39-42.
2. Hamilton R L,Wiley C A. Neuropathology of
Viral Infections of the Nervous System (Ch 17).
Textbook of Neuropathology Ed. Davis RL,
Robertson DM. 3. baskı, Baltimore, William-
Wilkins, 1997; 984-988.
3. Modlin JF, Jabbour JR, Witte JJ, Halsey NA.
Epidemiologic studies of measles vaccines and
subacute sclerosing panencephalitis. Pediatrics
1977; 59: 505-12.
4. Dyken PR, Maertens P. Viral Infections.
Pediatric Neuropathology. Ed: Duckett S. Baltimore,
Williams- Wilkins 1995;403-422.
5. Zilber N, Kahana E. Enviromental risk factor
subacute sclerozing panencephalitis. Acta
Neurol (Scan) 1998; 98: 49-54.
6. Dyken PR. Subacute sclerosing panencephalitis.
Current status. Neurologic Clinics.
Pediatric Neurology. Ed: Swaiman KF. Philadephia,
W.B. Saunders, 1985.
7. Horta-Barbosa L, Fuccillo DA, Sever JL, Zeman
W. Subacute sclerosing panencephalitis isolation
of measles virus from a brain biopsy.
Nature 1969; 221: 974.
8. Connolly JH, Haire M, Hadden DSM. Measles
immunoglobulins in subacute sclerosing panencephalitis.
Br Med J 1971; 1: 23-25.
9. Singer C, Long AE, Suchowesty O. Adult onset
subacute sclerosing panencephalitis: case
report and review of the literature. Mov Disord
1997; 12: 342-53.
10. Budka H. Viral Infections (Ch 8). Neuropathology
the Diagnostic Approach. Ed: Garcia
JH. 1. baskı. St Louis, Baltimore: Mosby 1997;
353-378.
11. Allen IV, Mc Quamid S, McMahon MP, Kirk J,
Mc Connell R. The significance of measles
virus antigen and genome distribution in the
CNS in SSPE for mechamisms of viral spread
and demiyelination. J Neuropathol Exp Neurol
1996; 55 : 471-480.
12. Baram TZ, Gonzalenz I, Xie ZD. Subacute
sclerosing panencephalitis in an infant:
Diagnostic role of viral genome analysis. Ann
Neurol 1994; 36: 103-108.
13. Esiri MM, Oppenheimer DR, Brownell B, Haire
M. Distribution of measles antigen and
immunglobulin containing cells in the CNS in
subacute sclerosing panencephalitis. J Neurol
Sci 1981; 53:29-43.
14. McQuaid S, Isserte S, Allan GM, Taylor MJ,
Allen TV, Cosby SL. Use of immunocytochemistry
and biotinylated in situ hybridization
for detecting measles virus in central
nervous sytem tissue. J Clin Pathol 1990;43:
329-333.
15. Kirk J, Zhou AL, Mc Quaid S, Cosby SL, Allen
IV. Cerebral endothelial infection by measles
virus in subacute sclerosing panencephalitis:
Ultrastrural and in situ hybridization evidence.
Neropath Apply Neurobiol 1991; 17: 289-297.
16. Budka H, Lassmann H, Popow, Kraupp T.
Measles virus antigen in panencephalitis. An
immunomorphological study stressing dendritic
involvment in SSPE. Acta Neuropathol 1982;
56 : 52-62
17. Shankar SK, Talby AB, Arunodaya GR, et al.
Peripheral neuropathy in subacute sclerosing
panencephalitis immunohistochemical and
ultrastructural evidence. Clin Neuropathol
1998; 17: 15-18.
18. Cathomen T, Naim HY, Cattaneo R. Measles
virus with altered envelope protein cytoplasmic
tails gain cell fusion competence. J Virol 1998;
72 :1224-1234.
19. Hall WW, Lamb RA, Choppin PW. Measles and
subacute sclerosing panencephalitis virus
proteins: Lack of antibodies to the M protein in
patients with subacute sclerosing panencephalitis.
Proc Natl Fed Sci 1979; 76: 2047-
2054.
20. Poser CM. Notes on the pathogenesis of
subacute sclerosing panencephalitis. J Neurol
Sci 1990; 95 : 219-214.
Thank you for copying data from http://www.arastirmax.com
